switching from semaglutide to tirzepatide dose between weight-loss medications How to Switch from Tirzepatide

Questions remain around affordability, patient adherence, and broad access in the Indian market

The STEP 2 trial showed 9.6 percent average weight loss at 68 weeks for diabetic participants versus 14.9 percent in STEP 1 (non-diabetic)

"I think we can foresee that there will obviously be more competition in terms of driving down the prices of these medications," she said

1 However, concerns were raised about the stigmatizing term fatty and the inclusion of two metabolic risk factors, as well as the allowance of more liberal alcohol use, thus distracting our attention from the natural history of the disease

But if youre still keen on getting any GLP-1 medication online, there are a few things you can do to limit any potential downsides

My take: Novo needed a clean win after months of ups/downs